This year was challenging to get through in many ways, but the space world was kicking ass. From Blue Origin and SpaceX making vertical booster landings look easy to the introduction of several new launch vehicles and launch sites, it was a busy space year. Overall, there were 85 launches and 3 failures in 2016 including 4 crew and 7 cargo flights to the ISS.
There were several notable firsts for ISS research as well, especially for those interested in microgravity molecular biology. Because of the multi-step, hands-on nature of life science benchwork, significant progress in this field has lumbered along from a lack of development of even the most basic assay resources for the ISS.
The majority of life science projects flown are one or two step experiments performed in self-contained modules with minimal to no crew interaction. The samples or modules is then returned and analyzed post-flight. If it didn’t fail, you may have the money to fly again. Maybe not. These constraints have seriously limited the pace of what can be accomplished in this field.
The developments seen on the ISS this year are important steps forward to remedy these challenges and create a ...